Sangamo BioSciences | SGMO - Zahlungsmittel Und Äquivalente

Aktienkurs
0.32
Täglich Wechseln
-0.02 -6.74%
Monatlich
-25.35%
Jährlich
-60.87%
Q1 Prognose
0.31




Zahlungsmittel Und Äquivalente Veränderung Datum
Alaunos Therapeutics USD 1.94M 941K 2025-09
Alnylam Pharmaceuticals USD 1.66B 167M 2025-12
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Amgen USD 9.13B 316M 2025-12
Bayer EUR 5.9B 1.34B 2025-09
BioCryst Pharmaceuticals USD 335.91M 251.83M 2025-12
Biogen USD 3.01B 854.3M 2025-12
BioMarin Pharmaceutical USD 1.31B 61.57M 2025-12
Cipla INR 7.96B 39.9M 2025-09
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 90.6M 83.14M 2025-12
CSL USD 2.16B 633M 2025-06
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Grifols EUR 979.78M 334.84M 2024-12
Ionis Pharmaceuticals USD 2.68B 437M 2025-12
J&J USD 19.71B 1.48B 2025-12
Karyopharm Therapeutics USD 37.67M 1.05M 2025-09
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
Pfizer USD 1.34B 295M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Tectonic Therapeutic USD 253.8M 14.64M 2025-12
Ultragenyx Pharmaceutical USD 202.51M 36.4M 2025-09
Vertex Pharmaceuticals USD 6.61B 321.1M 2025-12